BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

  Interviews  •  Sponsored by PharmCADD

Combining AI and Quantum Mechanics to Improve Drug and Vaccine Discovery

by Andrii Buvailo, PhD  (contributor )   •   March 22, 2022  

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

# AI & Digital   
Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

The application of Artificial Intelligence (AI) to accelerate and improve drug discovery has been a growing trend for several years in a row, with the increasing number of AI-inspired drug candidates entering clinical trials. While AI proved to be a powerful tool for modeling biological systems and helping generate optimal leads, it is important to remember that deep learning (DL) -- the heart of the modern “AI revolution” -- is only as good as the underlying data used to train models. Since the majority of AI-driven companies are “playing” with classical Newtonian mechanics to describe the motions of atoms and molecules, sometimes they can run into limitations of “classical physics” as a tool to describe biological systems, hence, lower ability to grasp the intricacies of biology. 

A small number of companies are combining the latest advances in artificial intelligence research with the application of quantum mechanics (QM) methods to more accurately describe the behavior of the electrons in atoms and molecules, thereby getting better prediction results for, let’s say, ligand-target binding scenarios. 

One such company, a South Korean biotech PharmCADD, caught my attention recently because of two reasons. One reason was that the company offered a platform-based AI-driven system for drug discovery, involving quantum physics modules -- a promising combination. Another reason -- the company focused on a surprisingly wide diversity of various drug modalities and target types, and it even had a clinical-stage mRNA-vaccine candidate in its pipeline -- in collaboration with an external partner.

Below is my interview with Dr. Sangwook Wu, CEO/CTO at PharmCADD, where he explains how their technology operates, what the role of AI and quantum physics in drug discovery is, and how drug makers can partner with such AI-platform companies as PharmCADD to leverage technology and enrich their pipelines with promising assets.

 

#advertisement
AI in Drug Discovery Report 2025

Continue reading

This content available exclusively for BPT Mebmers

 BPT Membership 

Topics: AI & Digital   

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

You may also be interested to read:

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)
by Andrii Buvailo
Merging AI and Quantum Computing To Boost Drug Discovery
by Andrii Buvailo
[Interview] The Rise of Quantum Physics in Drug Discovery
by Andrii Buvailo

 

#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.